Akcea Therapeutics 주식 가격. AKCA - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Akcea Therapeutics Inc (AKCA) 시세

Akcea Therapeutics Inc (AKCA)

18.17

0.00

(0.00%)

마감 01 3월 6:00AM

18.17

0.00

( 0.00% )

시간외 단일가: 9:00AM

개인 투자자를 위한 전문가급 도구.

가격

18.17

매수가

18.08

매도가

19.00

거래량

-

0.00 일간 변동폭 0.00

0.00 52주 범위 0.00

전일 종가

18.17

개장가

-

최근 거래 시간

마지막 거래 시간

-

평균 볼륨(3m)

-

재정 규모

-

VWAP

-

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR...

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more...

WAYLIVRA▼® (volanesorsen), the First & Only Therapy for FCS, an Ultra-Rare & Life-Threatening Condition, to Be Available o...

National Institute for Health and Care Excellence (NICE) issues a positive recommendation for volanesorsen to treat adults with Familial...

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics - Ionis to acquire remaining 24% of...

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020 Results from Phase 2 study demonstrate patients...

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020 Results in late-breaking...

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress...

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC...

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany WAYLIVRA is the only...

Akcea Reports Financial Results and Highlights for Second Quarter 2020

Akcea Reports Financial Results and Highlights for Second Quarter 2020 Global Net Product Revenues of $16...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

AKCA - Frequently Asked Questions (FAQ)

What is the current Akcea Therapeutics share price?

The current share price of Akcea Therapeutics is US$ 18.17

What is the 1 year trading range for Akcea Therapeutics share price?

Akcea Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

가장 활성
% 상승자
% 패자

기호	가격	볼륨
BTOGBit Origin Ltd	US$ 1.01 (454.95%)	69.01M
ACONAclarion Inc	US$ 6.15 (83.58%)	14.66M
FTFTFuture FinTech Group Inc	US$ 0.3397 (68.17%)	48.38M
BSCUInvesco BulletShares 2030 Corporate Bond ETF	US$ 24.99 (50.45%)	3
LGHLWLion Group Holding Ltd	US$ 0.0093 (38.81%)	10
BSCSInvesco Bulletshares 2028 Corporate Bond ETF	US$ 10.01 (-50.79%)	1
LXRXLexicon Pharmaceuticals Inc	US$ 0.3446 (-50.74%)	9.27M
TOIIWOncology Institute Inc	US$ 0.02 (-45.80%)	1
CTKBCytek Biosciences Inc	US$ 2.71 (-39.64%)	3
AGMHAGM Group Holdings Inc	US$ 0.1999 (-39.17%)	490.13k
BTOGBit Origin Ltd	US$ 1.01 (454.95%)	69.01M
FTFTFuture FinTech Group Inc	US$ 0.3397 (68.17%)	48.38M
ARBKArgo Blockchain PLC	US$ 0.438 (7.51%)	18.11M
TRNRInteractive Strength Inc	US$ 3.35 (30.35%)	17.25M
ACONAclarion Inc	US$ 6.15 (83.58%)	14.66M

Sidney

Sidney 7 년 전

Any thoughts on why so low today?

Thoro

Thoro 8 년 전

So Volatile. Any thoughts on why the big plunge today?

Rodney213

Rodney213 8 년 전

Like how clean the board is .Some heavy price target coverage today

dinosaurbob

dinosaurbob 8 년 전

Dropped heavy yesterday but bounced back some today. I am still up 17%, so I am not complaining.

Thoro

Thoro 8 년 전

This is a volatile stock. Its finding its legs.

dinosaurbob

dinosaurbob 8 년 전

Closed at $15.43 today up 47 cents.

dinosaurbob

dinosaurbob 8 년 전

Back up $1.02 today. This stock is like riding a roller coaster. Up one day and down the next. And big drops and rises too.

dinosaurbob

dinosaurbob 8 년 전

WTH happened today? Down $1.52!

dinosaurbob

dinosaurbob 8 년 전

Closed up 40 cents at $14.88

dinosaurbob

dinosaurbob 8 년 전

It was up big earlier but steadily dropping now. Still up 14 cents at 2:45 EST

Thoro

Thoro 8 년 전

AKCA, Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency

https://ih.advfn.com/p.php?pid=nmona&article=75321782

dinosaurbob

dinosaurbob 8 년 전

Closed up at $14.48 (5.16%). Nice!

Thoro

Thoro 8 년 전

I know it dropped, but I like when it tests higher.

dinosaurbob

dinosaurbob 8 년 전

Yes, but it dropped to $13.77. I still believe in it though.

Thoro

Thoro 8 년 전

AKCA $16.30 looked great today!

dinosaurbob

dinosaurbob 8 년 전

I bought in at 9.88 and then doubled my portfolio Friday at $13.00. I see this over $20.00 by October!

Thoro

Thoro 8 년 전

AKCA

IPO doing great first 5 days of trading.

Thoro

Thoro 8 년 전

AKCA

#MARKET NEWS
JULY 14, 2017 / 12:12 PM / 3 DAYS AGO
BRIEF-Akcea Therapeutics Inc shares open at $8.13 in debut vs IPO price of $8/share

http://www.reuters.com/article/brief-akcea-therapeutics-inc-shares-open-idUSFWN1K50CZ

Thoro

Thoro 8 년 전

AKCA

#MARKET NEWS
JULY 13, 2017 / 8:30 PM / 4 DAYS AGO

BRIEF-Akcea Therapeutics says public offering of 15.6 mln common shares priced at $8 per share

http://www.reuters.com/article/brief-akcea-therapeutics-says-public-off-idUSASA09X2O

Akcea Therapeutics

Simplify Market Neutral ...

SVB Financial (CE)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관